(Q53361774)

English

Efalizumab for patients with moderate to severe plaque psoriasis: a randomized controlled trial.

scientific article

Statements

Efalizumab for patients with moderate to severe plaque psoriasis: a randomized controlled trial (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit